Hepatic morphology and effects of intravenous injection of sodium propionate on plasma propionate and glucose in fed and fasted dairy cattle

Sodium propionate (3 mmol/kg) was injected IV into 8 nonlactating dairy cows before and after 6 days (144 hours) of fasting. During fasting, long-chain fatty acids in plasma increased from 0.30 +/- 0.05 (SE) mM to 1.09 +/- 0.15 mM (P less than 0.05). Liver fat increased from 0.5 +/- 0.3% to 9.3 +/- 1.7% (P less than 0.05). Half-life of injected sodium propionate increased significantly (P less than 0.05) from 7.6 +/- 0.5 minutes to 10.1 +/- 1.0 minutes during fasting. Sulfobromophthalein half-life did not change significantly (3.8 +/- 0.79 minutes to 5.3 +/- 1.3 minutes). Increases in plasma glucose concentrations after propionate loading were significantly less during fasting than during feeding. Thus, the change in glucose concentration served as an indicator of hepatic conversion of propionate to glucose. Increases in glucose concentration of less than 2 mM at 30 minutes after propionate loading indicated that liver function was altered in nonlactating dairy cows.     

The clinical administration of the opioid antagonist naloxone in dogs

The short introduction gives a review on the complex of exogen and endogen opioids and their receptors as well as on their pharmacodynamics, pharmacokinetics and toxicity of naloxone. The clinical efficacy of naloxone as an opioid antagonist is described. Applications of naloxone for the dog are specified: antagonisation of etorphine, morphine, levomethadone and fentanyl, antagonisation of exogen and endogen opioids in puppies and treatment of lactomania in the bitch. The mean effective dose to antagonize morphines is 0.003 mg/kg bodyweight. If persisting analgesia is indicated the dose of naloxone in titrating steps in 0.001 mg/kg bw. To antagonize postpartal hypoxia in puppies 0.02 mg per animal naloxone have to be injected. For treatment of lactomania a dose of 0.01 mg/kg bodyweight twice a day for a couple of days is recommended. The clinical effectivity of naloxone is proved doubtlessly. Compatibility and safety are very high.     

An international comparison of different laboratory tests for the diagnosis of bovine leukosis: suggestions for international standardization

A collaborative study was conducted to compare the detection limit of different laboratory tests for antibodies against bovine leukemia virus (BLV). Serum and milk samples were tested in agar gel immunodiffusion (AGID), different modifications of indirect ELISA, blocking ELISA and ELISA procedures using monoclonal antibodies to BLV gp51 or BLV p24. The detection limit of reference serum E4 diluted 2-fold in negative serum gave a median value of 1:16 in AGID, indirect ELISA, and monoclonal ELISA p24, 1:128 in monoclonal ELISA gp51, and 1:1024 in blocking ELISA. The detection limit of a 4% immunoglobulin preparation of E4 diluted in negative milk showed median values of 1:800 in indirect ELISA, 1:1000 in monoclonal ELISA, and 1:2400 in blocking ELISA. None of the ELISA procedures could detect all the positive individual milk samples diluted 1:50. The AGID test is the official reference test for detection of antibodies against BLV. Reference serum E4 diluted 1:10 in negative serum must be scored positive in the AGID test. It is suggested that an international reference serum standard be established rather than an official recommendation of a particular ELISA test.